Ventil Device Usefulness in Mechanically Ventilated ICU Patients
Assesment of Usefulness of Ventil Device for Mechanical Ventilation in ICU Patients
1 other identifier
interventional
40
1 country
1
Brief Summary
During Covid-19 pandemic many patients require mechanical ventilation due to disastrous impact of SARS-CoV-2 on lungs. In several countries there is a shortage of ICU beds and ventilators. Critically ill patients are treated outside ICUs. Doctors are facing ethical dilemmas who they should treat with ventilation, who should receive ventilator and who should but will not. In ICUs or step down units or in nursery homes there are also patients beyond hope treated - very often they are dependent on mechanical ventilation. Some attempts to invent a device that could replace complex machines in patients with anticipated poor outcome have been made. Ventil was used in clinical scenarios for separate lung ventilation with good effect. As a flow divider it has a potential to ventilate 2 patients at the same time. In the study Ventil will ventilate one patient and instead of the second there will be an artificial lung. Tidal volumes, minute ventilation, PEEP set and final will be checked. Ppeak, Pmean, Pplat, Cdyn, airway resistance, EtCO2, Sat O2, HR, SAP, DAP will be monitored every 2 hrs, as well as blood-gas analysis (every 8 hrs).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 15, 2020
CompletedFirst Submitted
Initial submission to the registry
April 16, 2020
CompletedFirst Posted
Study publicly available on registry
April 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedApril 27, 2020
April 1, 2020
16 days
April 16, 2020
April 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of cases in which it was necessary to stop using Ventil and to step- back to ventilation without this flow divider
Ventil will be removed from the patient-ventilator circiuit in case of episodes of desaturation \<90% (in pts without COPD) without reversibel reason; need for FiO2 increase by 10%; need for switch to other than CMV mode of ventillation need for neuromucular blockade or for deepen sedation because of assynchrony between patient and venilator cummulation of CO2\>45 mm Hg (in pts without COPD) not responding to the increase of minute ventilation for 30 minutes; if Pplat \>30 cmH2O; in case of new haemodynamic disturbances that cannot be explaned by other reasons; in case of increase or decrease of BP by 20%; increase or decrease of HR by 20%; in case of occurence of clinically important heart rhythm disturbances
48 hours
Study Arms (1)
mechanically ventilated patients
EXPERIMENTALAdult ICU patients who are mechanically ventilated and who do not require complex modes of ventilation. A designated flow divider (Ventil) will be used to divide inspiratory gas flow from ventilator in two separate streams - one to the patient and the second to the artificial lung
Interventions
Checking ventilation parameters set and obtained and clinical parameters while ventilating the patient and an artificial lung simultaneously, using inspiratory flow divider.
Eligibility Criteria
You may qualify if:
- ICU patients who require mechanical ventilation
You may not qualify if:
- Patients who require complex modes of ventilation will not be recruited
- The sudy in an individual patient be discontinued if case of:
- Respiratory Criteria:
- episodes of desaturation \<90% (in pts without COPD) without reversibel reason
- need for FiO2 increase by 10%
- need for switch to other than CMV mode of ventillation
- need for neuromucular blockade or for deepen sedation because of assynchrony between patient and venilator
- cummulation of CO2\>45 mm Hg (in pts without COPD) not responding to the increase of minute ventilation for 30 minutes
- Pplat \>30 cmH2O
- Circulatory criteria:
- New haemodynamic disturbances that cannot be explaned by other reasons
- ↑ or ↓of BP by 20%
- ↑ or ↓of HR by 20%
- clinically important heart rhythm disturbances
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of Gdansk
Gdansk, 80-214, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Radoslaw Owczuk, prof
Medical University of Gdansk
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- full professor
Study Record Dates
First Submitted
April 16, 2020
First Posted
April 21, 2020
Study Start
April 15, 2020
Primary Completion
May 1, 2020
Study Completion
December 31, 2020
Last Updated
April 27, 2020
Record last verified: 2020-04